Administrative Core
Administrative Core
批准号:
10001429
负责人:
DAVID W KIMBERLIN
金额:
$14.12万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-08-31
关键词:
Advisory CommitteesAntiviral AgentsAreaBiometryChildhoodClinical ResearchClinical TrialsCollaborationsCommunicable DiseasesCommunicationCongenital herpes simplexDataDevelopmentDiagnosis Clinical TrialsDiseaseEffectivenessElementsEnsureEnterovirusFeedbackFoundationsFutureHeartHumanIndividualInfrastructureKnowledgeLaboratoriesLeadershipLogisticsMissionModelingMonitorNeonatalParechovirusPerinatal InfectionPersonnel ManagementPoliciesPopulationPrincipal InvestigatorProceduresProcessProtocols documentationPublishingRare DiseasesReadinessResearchResearch PersonnelResearch Project GrantsResourcesSepsisSimplexvirusSiteStructureTimeTrainingVirus DiseasesWorkbiomarker evaluationburden of illnesscareercongenital cytomegaloviruscongenital infectiondata managementexperienceimplementation researchimprovedinnovationoperationpatient populationpediatric departmentpharmacometricsprogramssuccesstrial design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The mission of the Congenital and Perinatal Infections Consortium (CPIC) is to eliminate the disease burden
associated with rare pediatric viral diseases, focusing on congenital cytomegalovirus (CMV) disease, neonatal
herpes simplex virus (HSV) infection, and neonatal enterovirus (EV) and parechovirus (HPeV) sepsis, by
gathering multi-site data to improve diagnosis, clinical trial readiness, and treatment of these rare diseases.
The proposed CPIC administrative structure builds on the infrastructure, as well as the success, of our well-
established Collaborative Antiviral Study Group (CASG).
The CPIC Administrative Core will provide oversight, coordination, and logistical support for the operation of
the proposed Consortium. The specific aims of the Core are to: 1) allocate and manage personnel and the
financial accounts related to CPIC activities, and provide fiscal oversight of all cores and projects; 2) develop
and implement policies and procedures to be used by CPIC sites related to research projects and CPIC Cores;
3) oversee and monitor all internal communication between CPIC sites and external communication with the
Rare Diseases Clinical Research Network (RDCRN) Data Management and Coordinating Center (DMCC); and
4) evaluate the impact and effectiveness of the overall CPIC, its research projects, and its cores.
We have carefully selected a coalition of 28 sites that individually and collectively bring knowledge of our
disease areas, experience collaborating on the development and implementation of research protocols, and
close partnerships with their patient populations. All have worked closely together for at least the past 10
years, and in many cases for up to 30 years. Throughout that time, UAB has provided scientific, regulatory,
trial management, biostatistical, laboratory, and data management support for all studies. This collaboration
has resulted in long-standing relationships, refinement of research and communication processes, and a
collective understanding of knowledge gaps among sites. Our team will be led by David Kimberlin, MD, CPIC
Principal Investigator (PI). He will be assisted by a Program Director and a Fiscal Manager within the UAB
Central Unit to ensure timely completion of all day-to-day administrative details, including regulatory
coordination and budgetary matters. The CPIC Administrative Core will utilize an Executive Committee that
includes participation from three partner leads, as well as a representative from the National CMV Foundation,
which is the CPIC Stakeholder Group. It will oversee research projects, Core Leadership, and will receive
advice from an External Advisory Committee.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Valacyclovir Phase I Trial
-
批准号:10248359
-
项目类别:
-
资助金额:$22.59万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC)
-
批准号:10001427
-
项目类别:
-
资助金额:$138.39万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
EV Sepsis Natural History
-
批准号:10465119
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Valacyclovir Phase I Trial
-
批准号:10465120
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC)
-
批准号:10465116
-
项目类别:
-
资助金额:$137.68万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC)
-
批准号:9804080
-
项目类别:
-
资助金额:$205.56万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Project-001
-
批准号:10685152
-
项目类别:
-
资助金额:$0.67万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Letermovir Phase I Trial
-
批准号:10001433
-
项目类别:
-
资助金额:$17.09万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Letermovir Phase I Trial
-
批准号:10248360
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
EV Sepsis Natural History
-
批准号:10248358
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Administrative Core
-
批准号:10465117
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Letermovir Phase I Trial
-
批准号:10465121
-
项目类别:
-
资助金额:$23.34万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Longitudinal CMV
-
批准号:10248357
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
EV Sepsis Natural History
-
批准号:10001431
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Valacyclovir Phase I Trial
-
批准号:10001432
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Project-002
-
批准号:10685153
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Longitudinal CMV
-
批准号:10465118
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Longitudinal CMV
-
批准号:10001430
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Administrative Core
-
批准号:10248355
-
项目类别:
-
资助金额:$10.43万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC)
-
批准号:10248354
-
项目类别:
-
资助金额:$137.3万
-
财政年份:2019
-
负责人:DAVID W KIMBERLIN
-
依托单位:
海外基金